These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30814002)

  • 1. Bionanomaterials for the Delivery of Cancer Immunotherapy.
    Bourquin C
    Chimia (Aarau); 2019 Feb; 73(1-2):69-72. PubMed ID: 30814002
    [No Abstract]   [Full Text] [Related]  

  • 2. Amphiphilic nanoparticle delivery enhances the anticancer efficacy of a TLR7 ligand via local immune activation.
    Mottas I; Bekdemir A; Cereghetti A; Spagnuolo L; Yang YS; Müller M; Irvine DJ; Stellacci F; Bourquin C
    Biomaterials; 2019 Jan; 190-191():111-120. PubMed ID: 30415018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering Strategies for Lymph Node Targeted Immune Activation.
    Chen Y; De Koker S; De Geest BG
    Acc Chem Res; 2020 Oct; 53(10):2055-2067. PubMed ID: 32910636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering nanoparticle strategies for effective cancer immunotherapy.
    Yoon HY; Selvan ST; Yang Y; Kim MJ; Yi DK; Kwon IC; Kim K
    Biomaterials; 2018 Sep; 178():597-607. PubMed ID: 29576282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cascade Cytosol Delivery of Dual-Sensitive Micelle-Tailored Vaccine for Enhancing Cancer Immunotherapy.
    Jiang D; Mu W; Pang X; Liu Y; Zhang N; Song Y; Garg S
    ACS Appl Mater Interfaces; 2018 Nov; 10(44):37797-37811. PubMed ID: 30360105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convective diffusion of nanoparticles from the epithelial barrier toward regional lymph nodes.
    Dukhin SS; Labib ME
    Adv Colloid Interface Sci; 2013 Nov; 199-200():23-43. PubMed ID: 23859221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic Polymeric Mixed Micelles Targeting Lymph Nodes Trigger Enhanced Cellular and Humoral Immune Responses.
    Li C; Zhang X; Chen Q; Zhang J; Li W; Hu H; Zhao X; Qiao M; Chen D
    ACS Appl Mater Interfaces; 2018 Jan; 10(3):2874-2889. PubMed ID: 29285934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical Strategies to Enhance the Therapeutic Efficacy of Toll-like Receptor Agonist Based Cancer Immunotherapy.
    Lee SN; Jin SM; Shin HS; Lim YT
    Acc Chem Res; 2020 Oct; 53(10):2081-2093. PubMed ID: 32966047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles Targeting Lymph Nodes for Cancer Immunotherapy: Strategies and Influencing Factors.
    Li ZZ; Zhong NN; Cao LM; Cai ZM; Xiao Y; Wang GR; Liu B; Xu C; Bu LL
    Small; 2024 May; 20(19):e2308731. PubMed ID: 38327169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph Node Delivery Strategy Enables the Activation of Cytotoxic T Lymphocytes and Natural Killer Cells to Augment Cancer Immunotherapy.
    Jiang D; Gao T; Liang S; Mu W; Fu S; Liu Y; Yang R; Zhang Z; Liu Y; Zhang N
    ACS Appl Mater Interfaces; 2021 May; 13(19):22213-22224. PubMed ID: 33955746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
    Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
    Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective cancer immunotherapy in mice by polyIC-imiquimod complexes and engineered magnetic nanoparticles.
    Bocanegra Gondan AI; Ruiz-de-Angulo A; Zabaleta A; Gómez Blanco N; Cobaleda-Siles BM; García-Granda MJ; Padro D; Llop J; Arnaiz B; Gato M; Escors D; Mareque-Rivas JC
    Biomaterials; 2018 Jul; 170():95-115. PubMed ID: 29656235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation.
    Widmer J; Thauvin C; Mottas I; Nguyen VN; Delie F; Allémann E; Bourquin C
    Int J Pharm; 2018 Jan; 535(1-2):444-451. PubMed ID: 29157965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nano-Immune-Engineering Approaches to Advance Cancer Immunotherapy: Lessons from Ultra-pH-Sensitive Nanoparticles.
    Li S; Bennett ZT; Sumer BD; Gao J
    Acc Chem Res; 2020 Nov; 53(11):2546-2557. PubMed ID: 33063517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local targets for immune therapy to cancer: tumor draining lymph nodes and tumor microenvironment.
    Fransen MF; Arens R; Melief CJ
    Int J Cancer; 2013 May; 132(9):1971-6. PubMed ID: 22858832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph nodes and human tumors (review).
    Lores B; García-Estevez JM; Arias C
    Int J Mol Med; 1998 Apr; 1(4):729-33. PubMed ID: 9852289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unlocking the therapeutic potential of primary tumor-draining lymph nodes.
    Rotman J; Koster BD; Jordanova ES; Heeren AM; de Gruijl TD
    Cancer Immunol Immunother; 2019 Oct; 68(10):1681-1688. PubMed ID: 30944963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facile preparation of a metal-phenolic network-based lymph node targeting nanovaccine for antitumor immunotherapy.
    Su Q; Liu Z; Du R; Chen X; Chen L; Fu Z; Luo X; Yang Y; Shi X
    Acta Biomater; 2023 Mar; 158():510-524. PubMed ID: 36603733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.